John K. Nelson
About John K. Nelson
Independent Board Member of Nuveen California AMT‑Free Quality Municipal Income Fund (NKX); born 1962; Class II trustee with current term expiring at the 2026 annual meeting; service on the Nuveen fund complex boards since 2013 . Former CEO of ABN AMRO Bank N.V. North America and Global Head of the Financial Markets Division; prior senior external advisor to Deloitte Consulting’s Financial Services practice; Fordham University BA (Economics) and MBA (Finance) . Deemed an Independent Board Member (not an “interested person” under the Investment Company Act) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| ABN AMRO Bank N.V. (incl. LaSalle Bank Corp.) | CEO North America; Global Head, Financial Markets (FX, Commodities, Fixed Income, EM, Derivatives) | 1996–2008 (various leadership roles); Global Head 2007–2008 | Member, Federal Reserve FX Committee; representation on committees of Bank of Canada, ECB, Bank of England |
| Deloitte Consulting LLP | Senior External Advisor, Financial Services | 2012–2014 | Strategy advisory to FS practice |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Core12 LLC (private) | Director | 2008–2023 | Branding/marketing/communications firm |
| Fordham University | Member, President’s Council | 2010–2019 | University advisory role |
| Fordham University | Director, Curran Center for Catholic American Studies | 2009–2018 | Academic center governance |
| Marian University | Trustee and Chair, Board of Trustees | 2011–2013 | Board leadership |
Board Governance
- Independence: Not an “interested person” of the Funds, the Adviser, TIAA or Nuveen; all current trustees are Independent Board Members .
- Committee leadership and memberships:
- Audit Committee: Chair; designated “audit committee financial expert” .
- Executive Committee: Member (with Board Chair Young, Kenny, Toth) .
- Dividend Committee: Member .
- Nominating & Governance Committee: Member .
- Investment Committee: Member .
- Closed‑End Fund Committee: Member .
- Attendance: Each Board Member attended at least 75% of Board and committee meetings in the last fiscal year .
- Meeting intensity (last fiscal year, NKX): 6 regular Board; 9 special Board; 3 Executive; 8 Dividend; 4 Compliance/Risk; 13 Audit; 6 Nominating & Governance; 3 Investment; 4 Closed‑End Funds .
- Board Chair is independent (Robert L. Young), reinforcing board independence and agenda control .
Fixed Compensation
Compensation structure effective January 1, 2025 for Independent Board Members (allocated across the Nuveen fund complex):
| Component | Amount (USD) | Notes |
|---|---|---|
| Annual Board Retainer | $350,000 | All Independent Board Members |
| Audit Committee Membership | $35,000 | Per member; chair receives an additional $35,000 |
| Compliance/Risk Committee Membership | $35,000 | Per member |
| Investment Committee Membership | $30,000 | Per member; chair/co‑chair $30,000 |
| Dividend Committee Membership | $25,000 | Per member |
| Nominating & Governance Committee Membership | $25,000 | Per member |
| Closed‑End Funds Committee Membership | $25,000 | Per member |
| Board Chair Premium (not applicable to Nelson) | $150,000 | Independent Chair only |
| Ad hoc meeting fees | $1,000 or $2,500 | Based on length/immediacy |
| Special assignment committees | Chair/Co‑Chair: from $1,250/quarter; Members: from $5,000/quarter | As constituted |
Actual paid compensation (latest fiscal year):
- Aggregate compensation paid by NKX to Nelson: $2,792 .
- Total compensation paid from all Nuveen funds to Nelson: $483,250 (includes allocations and any deferred amounts) .
Deferred compensation plan is available; amounts are credited to a book reserve account mirroring chosen Nuveen fund investments; distributions can be lump sum or 2–20 years; Funds have no retirement or pension plans .
Performance Compensation
- No performance‑based cash bonus, stock awards, options, or ESG/TSR/financial metric‑linked compensation disclosed for Independent Board Members .
- Deferred compensation (participating funds) reported for Nelson: $0 in the disclosed table, indicating no current deferral balance in participating funds as of the report .
Other Directorships & Interlocks
| Company/Institution | Type | Role | Potential Interlock/Conflict Considerations |
|---|---|---|---|
| Core12 LLC | Private company | Director (2008–2023) | No disclosed transactions with Nuveen funds; limited conflict risk |
| Fordham University (President’s Council) | Non‑profit/academic | Member (2010–2019) | No fund‑related dealings disclosed |
| Curran Center for Catholic American Studies | Academic | Director (2009–2018) | No fund‑related dealings disclosed |
| Marian University | Academic | Trustee & Chair (2011–2013) | No fund‑related dealings disclosed |
No related‑party transactions concerning Nelson are disclosed; Section 16(a) filings were compliant across trustees and officers in the last fiscal year .
Expertise & Qualifications
- Deep global markets and banking leadership (FX, commodities, fixed income, derivatives, EM) from ABN AMRO/LaSalle, including risk oversight and financial controls experience .
- Audit Committee Financial Expert designation and current Audit Committee Chair for the Funds .
- Academic credentials: BA Economics and MBA Finance, Fordham University .
Equity Ownership
| Measure | NKX | Fund Complex Aggregate |
|---|---|---|
| Shares beneficially owned | 0 | Dollar range “Over $100,000” across all registered investment companies overseen (aggregate) |
| Ownership % of shares outstanding | <1% for each fund, trustee level | Each trustee’s holdings <1% of each fund’s outstanding shares |
| Deferred compensation balance (participating funds) | $0 | Reported $0 deferrals for Nelson in the participating funds table |
| Pledged shares | None disclosed | None disclosed |
Stock ownership governance principle: Trustees are expected to invest at least one year of compensation in Nuveen funds, directly or on a deferred basis; beneficial ownership per‑fund is $0 for NKX, aggregate is “Over $100,000,” and disclosed deferrals for Nelson show $0, which may indicate a shortfall versus the guideline absent other holdings not itemized beyond the aggregate range .
Governance Assessment
-
Strengths:
- Independent director with extensive financial markets and risk oversight background; serves as Audit Committee Chair and SEC‑defined Financial Expert, supporting financial reporting quality and valuation oversight .
- Broad committee engagement (Audit, Executive, Dividend, Nominating & Governance, Investment, Closed‑End), providing comprehensive governance touchpoints across risk, performance, and shareholder distribution policies .
- Attendance at or above the 75% threshold, consistent with engaged oversight; high meeting cadence at NKX (13 Audit; 6 N&G; multiple Board/committee meetings) demonstrates active governance workload .
-
Potential alignment concerns:
- NKX specific beneficial ownership is $0 and aggregate fund complex holdings reported only as “Over $100,000,” while the board’s principle expects at least one year’s compensation invested (Nelson’s total compensation $483,250); disclosed deferral balance is $0, suggesting lower visible alignment relative to the guideline unless other unlisted holdings satisfy the expectation (disclosure is aggregate by range, not precise) .
- No related‑party or interlock conflicts disclosed for Nelson; overall low direct conflict risk; the proxy highlights one trustee’s external private investment interests (Kenny), but none for Nelson .
-
Signals for investors:
- Audit chairmanship and expert designation are positive governance signals for financial reporting integrity and valuation oversight in a leverage‑using closed‑end fund structure .
- Visible alignment could be strengthened by higher disclosed direct/deferred holdings consistent with the board’s investment principle; current reporting is limited to range data and shows $0 in NKX .
Board Governance (Detail Table)
| Committee | Role | Key Oversight |
|---|---|---|
| Audit | Chair; Financial Expert | Financial reporting, auditor oversight, valuation policy and designee oversight |
| Executive | Member | Acts with full Board authority between meetings |
| Dividend | Member | Declares distributions (ratified by Board) |
| Compliance, Risk Mgmt & Regulatory Oversight | Not listed as member | Oversight of compliance and enterprise/product risks (liquidity, leverage, derivatives) |
| Nominating & Governance | Member | Board composition, evaluations, governance guidelines, director compensation reviews |
| Investment | Member | Performance oversight, investment risk review, leverage/hedging assessments |
| Closed‑End Funds | Member | Premium/discounts, leverage, market dynamics, repurchases/issuance reviews |
Director Compensation (Detail Table)
| Item | Amount | Source |
|---|---|---|
| NKX aggregate compensation to Nelson (latest FY) | $2,792 | |
| Total compensation from all Nuveen funds to Nelson (latest FY) | $483,250 | |
| Deferred compensation plan availability | Yes; book account mirrors Nuveen fund investments; no pensions | |
| Nelson deferred compensation balance (participating funds table) | $0 |
Insider Filings and Compliance
- Section 16(a) and 30(h) filings: Funds report full compliance by trustees and officers in the last fiscal year; no delinquent reports noted .
RED FLAGS
- Low disclosed NKX ownership (0 shares) and only “Over $100,000” aggregate range versus one‑year compensation expectation; no current deferred compensation balance disclosed for Nelson, which may be viewed as weaker ownership alignment pending fuller holdings detail .
- No related‑party transactions or tax gross‑ups, option repricing, or other compensation anomalies disclosed for Nelson; no legal proceedings indicated in proxy materials .